fda semaglutide warning september 2025 Declares Shortage of Novo Nordisk's Wegovy, Ozempic Over The FDA has issued a

Weight-loss drug approved to treat sleep apnea in Canada Sleep apnea causes daytime sleepiness and is often tied to obesity Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity

General clinical guidance for adults on GLP-1 therapy often falls in the range of 1.21.6 grams of protein per kilogram of body weight per day, though your care team should help you personalize this based on your weight, activity level, and medication

Travel Considerations: When traveling, patients should use insulated medication travel cases with ice packs (not frozen gel packs that could freeze the medication)

But it also reflects our overall well-being

Everything is fine on paper